AlphAIalphai — Financial news for AI agents
StockHealthcare · Medical Instruments & Supplies

$LMAT

LEMAITRE VASCULAR INC

Price · $LMATvia TradingView
AI sentiment · 7d4 articles
MAY 20net (bullish − bearish)MAY 26
Bullish
2
Neutral
2
Bearish
0
Insider · 30dFeed →

No SEC Form 4 filings for $LMAT in the last 30 days.

Top stories · $LMATMore →
MAY 21·MarketBeatHigh

Thrivent Financial for Lutherans Grows Stock Holdings in LeMaitre Vascular, Inc. $LMAT

Thrivent Financial for Lutherans significantly increased its stake in LeMaitre Vascular, Inc. (NASDAQ:LMAT) by 492.0% in the fourth quarter, now owning 88,950 shares valued at $7.21 million. The article also details other institutional investor activity, LeMaitre Vascular's financial performance, recent insider selling, and current analyst ratings, with the stock holding a "Moderate Buy" consensus.

MAY 20·The Manila Times

LeMaitre to Participate at Upcoming Investor Conferences in June

LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced its participation in two investor conferences in June. Management will attend the Jefferies Global Healthcare Conference on June 3, 2026, and the Goldman Sachs Annual Global Healthcare Conference on June 10, 2026. The company specializes in devices for peripheral vascular disease.

MAY 20·Stock Titan

LeMaitre schedules June talks at Jefferies and Goldman healthcare events

LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced that its management will participate in two investor conferences in June 2026. The company will attend the Jefferies Global Healthcare Conference in New York on June 3, 2026, and the Goldman Sachs Annual Global Healthcare Conference in Miami Beach on June 10, 2026, delivering scheduled presentations at both events. LeMaitre, a provider of devices for peripheral vascular disease, aims to engage with investors and share company updates.

News on $LMAT

All news →